PGRMC1 may regulate the proliferation and progression of breast cancer cells, potentially by altering lipid metabolism and by activating key oncogenic signaling pathways, such as ERα expression and activation, as well as EGFR signaling (Asperger et al., 2020). Here, EGFR is linked to breast carcinoma.